NEW YORK (GenomeWeb News) – Nextval has received a $500,000 Phase II SBIR grant from the National Science Foundation to support further development and commercialization of its high-throughput screening system that employs mass spectrometry imaging and microarrays.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.